Maelle Anciaux, L. Ameye, T. Guiot, P. Flamen, S. Goldman, P. Demetter, A. Deleporte, A. Gossum, M. Paesmans, V. Donckier, A. Hendlisz, C. Vandeputte
{"title":"摘要1610:皮肤下:食管癌预后中的脂肪质量","authors":"Maelle Anciaux, L. Ameye, T. Guiot, P. Flamen, S. Goldman, P. Demetter, A. Deleporte, A. Gossum, M. Paesmans, V. Donckier, A. Hendlisz, C. Vandeputte","doi":"10.1158/1538-7445.SABCS18-1610","DOIUrl":null,"url":null,"abstract":"INTRODUCTION The last few years have seen an increased interest in the role of body mass composition parameters in cancer survival. this study sought to assess the impact of the body mass composition (BMC) on prognosis of locally advanced esophageal cancer (EC) patients beyond the usual quantitative weight loss associated with this condition. METHODS Diagnostic CT scans were assessed for BMC in 155 all-stage EC patients at diagnosis. The index (area/height 2 ) of skeletal muscle (SMI), subcutaneous (SFI) and visceral fat (VFI) were delineated on two adjacent slides at the third lumbar vertebra level by two independent investigators using PLANET ONCO® software (DOSIsoft, France). Mean attenuation (or density) of fat tissue was measuring to assess the quality of adipose compartments. Survival and relapse free survival (RFS) were calculated from date of baseline CT-scan. RESULTS Interobserver correlations were excellent for all BMC parameters measured (r = 0.94 to 0.99). Remarkably, low subcutaneous fat density (SFD) was associated to better outcome, as were low disease stages. Low C-reactive protein (CRP) levels were also associated with better overall survival (OS). In contrast, low BMI did not affect the patients’ outcome. Relapse free survival (RFS) analysis showed that only high disease stages and SFD remained associated with poor RFS. Stepwise regression showed that the combination of SFD, stage and CRP was an effective model for OS prediction. No parameter was retained for RFS in the multivariate analysis. Detailed results are shown in Table 1. CONCLUSION SFD, stages and CRP appeared as robust prognostic factors of OS in EC patients, in contrast with BMI. While SFD and stages were significant in RFS univariate analysis, none of these two parameters were retained in multivariate analyses. These results confirm the validity of BMC assessment for evaluating patient prognosis and show for the first time that adipose tissues and inflammation may have a preponderant impact on cancer prognosis. Citation Format: Maelle Anciaux, Lieveke Ameye, Thomas Guiot, Patrick Flamen, Serge Goldman, Pieter Demetter, Amelie Deleporte, Andre Van Gossum, Marianne Paesmans, Vincent Donckier, Alain Hendlisz, Caroline Vandeputte. Getting under the skin: Fat quality in esophageal cancer prognosis [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 1610.","PeriodicalId":20357,"journal":{"name":"Prevention, Early Detection, and Interception","volume":"186 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Abstract 1610: Getting under the skin: Fat quality in esophageal cancer prognosis\",\"authors\":\"Maelle Anciaux, L. Ameye, T. Guiot, P. Flamen, S. Goldman, P. Demetter, A. Deleporte, A. Gossum, M. Paesmans, V. Donckier, A. Hendlisz, C. Vandeputte\",\"doi\":\"10.1158/1538-7445.SABCS18-1610\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"INTRODUCTION The last few years have seen an increased interest in the role of body mass composition parameters in cancer survival. this study sought to assess the impact of the body mass composition (BMC) on prognosis of locally advanced esophageal cancer (EC) patients beyond the usual quantitative weight loss associated with this condition. METHODS Diagnostic CT scans were assessed for BMC in 155 all-stage EC patients at diagnosis. The index (area/height 2 ) of skeletal muscle (SMI), subcutaneous (SFI) and visceral fat (VFI) were delineated on two adjacent slides at the third lumbar vertebra level by two independent investigators using PLANET ONCO® software (DOSIsoft, France). Mean attenuation (or density) of fat tissue was measuring to assess the quality of adipose compartments. Survival and relapse free survival (RFS) were calculated from date of baseline CT-scan. RESULTS Interobserver correlations were excellent for all BMC parameters measured (r = 0.94 to 0.99). Remarkably, low subcutaneous fat density (SFD) was associated to better outcome, as were low disease stages. Low C-reactive protein (CRP) levels were also associated with better overall survival (OS). In contrast, low BMI did not affect the patients’ outcome. Relapse free survival (RFS) analysis showed that only high disease stages and SFD remained associated with poor RFS. Stepwise regression showed that the combination of SFD, stage and CRP was an effective model for OS prediction. No parameter was retained for RFS in the multivariate analysis. Detailed results are shown in Table 1. CONCLUSION SFD, stages and CRP appeared as robust prognostic factors of OS in EC patients, in contrast with BMI. While SFD and stages were significant in RFS univariate analysis, none of these two parameters were retained in multivariate analyses. These results confirm the validity of BMC assessment for evaluating patient prognosis and show for the first time that adipose tissues and inflammation may have a preponderant impact on cancer prognosis. Citation Format: Maelle Anciaux, Lieveke Ameye, Thomas Guiot, Patrick Flamen, Serge Goldman, Pieter Demetter, Amelie Deleporte, Andre Van Gossum, Marianne Paesmans, Vincent Donckier, Alain Hendlisz, Caroline Vandeputte. Getting under the skin: Fat quality in esophageal cancer prognosis [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 1610.\",\"PeriodicalId\":20357,\"journal\":{\"name\":\"Prevention, Early Detection, and Interception\",\"volume\":\"186 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Prevention, Early Detection, and Interception\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1158/1538-7445.SABCS18-1610\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Prevention, Early Detection, and Interception","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/1538-7445.SABCS18-1610","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
在过去的几年里,人们对身体质量组成参数在癌症生存中的作用越来越感兴趣。本研究旨在评估身体质量组成(BMC)对局部晚期食管癌(EC)患者预后的影响,而不是与该疾病相关的通常定量体重减轻。方法对155例全期EC患者在诊断时进行BMC诊断性CT扫描。由两名独立调查员使用PLANET ONCO®软件(DOSIsoft,法国)在相邻的两张载片上描绘第三腰椎水平的骨骼肌(SMI)、皮下(SFI)和脂肪(VFI)指数(面积/高度2)。测量脂肪组织的平均衰减(或密度)以评估脂肪隔室的质量。生存率和无复发生存率(RFS)从基线ct扫描日期计算。结果所有测量的BMC参数的观察者间相关性都很好(r = 0.94 ~ 0.99)。值得注意的是,低皮下脂肪密度(SFD)与较好的预后相关,疾病分期也较低。低c反应蛋白(CRP)水平也与更好的总生存期(OS)相关。相比之下,低BMI并不影响患者的预后。无复发生存(RFS)分析显示,只有高疾病分期和SFD仍与低RFS相关。逐步回归分析结果表明,SFD、分期及CRP是预测OS的有效模型。在多变量分析中,RFS没有保留任何参数。详细结果见表1。结论与BMI相比,SFD、分期和CRP是影响EC患者OS预后的重要因素。虽然SFD和分期在RFS单变量分析中很重要,但在多变量分析中这两个参数都没有保留。这些结果证实了BMC评估患者预后的有效性,并首次表明脂肪组织和炎症可能对癌症预后有显著影响。引文格式:Maelle Anciaux, Lieveke Ameye, Thomas Guiot, Patrick Flamen, Serge Goldman, Pieter Demetter, Amelie Deleporte, Andre Van Gossum, Marianne Paesmans, Vincent Donckier, Alain Hendlisz, Caroline Vandeputte。皮肤下:食管癌预后中的脂肪质量[摘要]。摘自:2019年美国癌症研究协会年会论文集;2019年3月29日至4月3日;亚特兰大,乔治亚州。费城(PA): AACR;癌症杂志,2019;79(13增刊):摘要第1610期。
Abstract 1610: Getting under the skin: Fat quality in esophageal cancer prognosis
INTRODUCTION The last few years have seen an increased interest in the role of body mass composition parameters in cancer survival. this study sought to assess the impact of the body mass composition (BMC) on prognosis of locally advanced esophageal cancer (EC) patients beyond the usual quantitative weight loss associated with this condition. METHODS Diagnostic CT scans were assessed for BMC in 155 all-stage EC patients at diagnosis. The index (area/height 2 ) of skeletal muscle (SMI), subcutaneous (SFI) and visceral fat (VFI) were delineated on two adjacent slides at the third lumbar vertebra level by two independent investigators using PLANET ONCO® software (DOSIsoft, France). Mean attenuation (or density) of fat tissue was measuring to assess the quality of adipose compartments. Survival and relapse free survival (RFS) were calculated from date of baseline CT-scan. RESULTS Interobserver correlations were excellent for all BMC parameters measured (r = 0.94 to 0.99). Remarkably, low subcutaneous fat density (SFD) was associated to better outcome, as were low disease stages. Low C-reactive protein (CRP) levels were also associated with better overall survival (OS). In contrast, low BMI did not affect the patients’ outcome. Relapse free survival (RFS) analysis showed that only high disease stages and SFD remained associated with poor RFS. Stepwise regression showed that the combination of SFD, stage and CRP was an effective model for OS prediction. No parameter was retained for RFS in the multivariate analysis. Detailed results are shown in Table 1. CONCLUSION SFD, stages and CRP appeared as robust prognostic factors of OS in EC patients, in contrast with BMI. While SFD and stages were significant in RFS univariate analysis, none of these two parameters were retained in multivariate analyses. These results confirm the validity of BMC assessment for evaluating patient prognosis and show for the first time that adipose tissues and inflammation may have a preponderant impact on cancer prognosis. Citation Format: Maelle Anciaux, Lieveke Ameye, Thomas Guiot, Patrick Flamen, Serge Goldman, Pieter Demetter, Amelie Deleporte, Andre Van Gossum, Marianne Paesmans, Vincent Donckier, Alain Hendlisz, Caroline Vandeputte. Getting under the skin: Fat quality in esophageal cancer prognosis [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 1610.